CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)
 
     
 
 
 
Tibet Rhodiola Pharmaceutical Holding Company Company Snapshot
Business Description:
Tibet Rhodiola Pharmaceutical Holding Company operates in the Medicinals and botanicals sector. Tibet Rhodiola Pharmaceutical Holding Co. is principally engaged in the production and distribution of pharmaceuticals. The Company operates its businesses through the wholesaling of pharmaceuticals and others, as well as the distribution of proprietary drug products. The Company operates its businesses primarily in Southwest China, Beijing, Shanghai, Guangdong province and other regions. In our complete report available for purchase the company is compared to: Jilin Aodong Medicine Industry (Group) Co., Ltd., Tianjin Tianyao Pharmaceutical, Ltd. and Anhui Fengyuan Pharmaceutical.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tibet Rhodiola Pharmaceutical Holding Company
  Stock Performance Chart for Tibet Rhodiola Pharmaceutical Holding Company
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 11.20
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 12.6%  
4 Weeks -17.6%   52 Weeks -25.9%  
 
Tibet Rhodiola Pharmaceutical Holding Company Key Data:
  Ticker: 600211 Country: CHINA
  Exchanges: SHG Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 1,110,729,000
(Year Ending Jan 2011).
Employees: 1,160
  Currency: Chinese Renmimbi Market Cap: 1,630,596,800
  Fiscal Yr Ends: December Shares Outstanding: 145,589,000
  Share Type: A Gu Closely Held Shares: N/A
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.